Next Article in Journal
Long COVID-19: An Emerging Pandemic in Itself
Previous Article in Journal
EBUS-TBNA in Children: The Road Less Travelled
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
ARM
Volume 89
Issue 2
10.5603/ARM.a2021.0023
arm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Letter

Antifibrotics for COVID-19 Related Lung Fibrosis: Agents with Benefits?

by
Mayank Mishra
* and
Girish Sindhwani
All India Institute of Medical Sciences, Rishikesh, India
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2021, 89(2), 231-233; https://doi.org/10.5603/ARM.a2021.0023
Submission received: 23 October 2020 / Revised: 11 December 2020 / Accepted: 11 December 2020 / Published: 30 April 2021

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an exponentially spreading pandemic with more than 36 million confirmed cases and over one million deaths worldwide, all within ten months of its first case in Wuhan, China [...]

Share and Cite

MDPI and ACS Style

Mishra, M.; Sindhwani, G. Antifibrotics for COVID-19 Related Lung Fibrosis: Agents with Benefits? Adv. Respir. Med. 2021, 89, 231-233. https://doi.org/10.5603/ARM.a2021.0023

AMA Style

Mishra M, Sindhwani G. Antifibrotics for COVID-19 Related Lung Fibrosis: Agents with Benefits? Advances in Respiratory Medicine. 2021; 89(2):231-233. https://doi.org/10.5603/ARM.a2021.0023

Chicago/Turabian Style

Mishra, Mayank, and Girish Sindhwani. 2021. "Antifibrotics for COVID-19 Related Lung Fibrosis: Agents with Benefits?" Advances in Respiratory Medicine 89, no. 2: 231-233. https://doi.org/10.5603/ARM.a2021.0023

Article Metrics

Back to TopTop